U.S. doctors online nowAsk doctors free
A female asked:

Hello, shall i allways have zometa and herceptin (trastuzumab) for her 2 breast cancer bone metastasis? or, is zometa with femara enough? thanks a lot

1 doctor answer2 doctors weighed in
Dr. Le Wang
Dr. Le Wanganswered
Internal Medicine 38 years experience
Her2-pos Breast Ca: Herceptin (trastuzumab) is indicated for Her2-pos metastatic BC. Duration of therapy in metastatic setting is not well defined. Usually it continues as long as it works or discontinued due to toxicity. Zometa is indicated for bone metastasis in most solid tumors. It carries a risk for osteonecrosis of jaw. Usually it is stopped after 2 yrs if not earlier. Femara is for post-menopausal BC who has positive ER/PR.
Created for people with ongoing healthcare needs but benefits everyone.

Related questions

A 36-year-old member asked:
What do I need to know about herceptin (trastuzumab) after breast cancer?
1 doctor answer4 doctors weighed in
A 48-year-old member asked:
Does being on herceptin (trastuzumab) for breast cancer cause you to gain weight?
3 doctor answers5 doctors weighed in
A 38-year-old member asked:
Why is herceptin (trastuzumab) licensed for use of advanced but not early breast cancer?
3 doctor answers5 doctors weighed in
Last updated Mar 13, 2015


Content on HealthTap (including answers) should not be used for medical advice, diagnosis, or treatment, and interactions on HealthTap do not create a doctor-patient relationship. Never disregard or delay professional medical advice in person because of anything on HealthTap. Call your doctor or 911 if you think you may have a medical emergency.